Congestive Heart Failure: Relevant Treatment and Equipment
Year: 2025
Type: article
Abstract: The disease known as congestive heart failure (CHF) occurs when the heart cannot pump enough blood to the body. The increasing need for innovative treatments is a result of the ongoing rise in the overall number of congestive heart failure cases and the resulting financial burden. Many congestive heart failure medications have showed some promise in preclinical and early-phase clinical studies, but the majority of them failed to demonstrate any meaningful effect in pivotal trials. The US Food and Drug Administration recently approved two new, promising medications to treat congestive heart failure: ivabradine and sacubitril/valsartan. and tissues, as a result of one-part failure, causing the heart to pool blood. Non-pharmacological intervention is crucial to the therapy of congestive heart failure in addition to pharmacological treatment.
Author: Harshali Thakare, Siddhant Sankhe*
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7083584867
FWCI:
Cites:
Cited by:
Related to: